Fidelis Capital Partners LLC Buys New Position in The Allstate Co. (NYSE:ALL)

Fidelis Capital Partners LLC purchased a new position in shares of The Allstate Co. (NYSE:ALL) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,127 shares of the insurance provider’s stock, valued at approximately $217,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Northwest Investment Counselors LLC bought a new position in Allstate during the third quarter worth $28,000. Versant Capital Management Inc raised its position in shares of Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Allstate in the 2nd quarter valued at about $38,000. MCF Advisors LLC boosted its position in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares in the last quarter. Finally, First Command Advisory Services Inc. acquired a new stake in Allstate during the second quarter worth approximately $58,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Buying and Selling

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is owned by company insiders.

Allstate Stock Performance

NYSE ALL opened at $186.49 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The company has a fifty day moving average price of $188.80 and a 200-day moving average price of $175.03. The Allstate Co. has a 1 year low of $125.63 and a 1 year high of $198.79. The firm has a market cap of $49.22 billion, a price-to-earnings ratio of 41.17, a PEG ratio of 1.74 and a beta of 0.48.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same quarter last year, the business posted $0.81 EPS. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. As a group, equities research analysts predict that The Allstate Co. will post 15.19 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ALL. UBS Group increased their price target on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Barclays raised their price target on shares of Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a report on Thursday. The Goldman Sachs Group upped their price objective on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a report on Thursday, August 15th. BMO Capital Markets raised their target price on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Finally, Bank of America upped their price target on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $207.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.